Maarten Van Roy

Animal models in translational medicine: Validation and prediction

Tinneke Denayer, Thomas Stöhr, Maarten Van Roy · European Journal of Molecular & Clinical Medicine · 2014 · 440 citations · Full text

Translational Medicine, Xenotransplantation, Preclinical Drug Evaluation +12

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 176 citations · Full text

Inflammation, Rheumatology, Rheumatoid Disorder +10

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

David Maussang, Azra Mujić-Delić, Francis J. Descamps et al. · Journal of Biological Chemistry · 2013 · 140 citations · Full text

Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium

Filip Van Hauwermeiren, Marietta Armaka, Niki Karagianni et al. · Journal of Clinical Investigation · 2013 · 79 citations · Full text

Apoptosis, Immune Regulation, Immunology +20

Reperfusion of cerebral artery thrombosis by the GPIb–VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

Stefania Momi, Michela Tantucci, Maarten Van Roy et al. · Blood · 2013 · 68 citations · Full text